Thomasville National Bank’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $138K | Hold |
15,000
| – | – | 0.01% | 221 |
|
|
2025
Q1 | $129K | Hold |
15,000
| – | – | 0.01% | 230 |
|
|
2024
Q4 | $161K | Sell |
15,000
-1,250
| -8% | -$13.4K | 0.01% | 229 |
|
|
2024
Q3 | $92.3K | Hold |
16,250
| – | – | 0.01% | 235 |
|
|
2024
Q2 | $68.6K | Hold |
16,250
| – | – | 0.01% | 235 |
|
|
2024
Q1 | $82.7K | Hold |
16,250
| – | – | 0.01% | 236 |
|
|
2023
Q4 | $151K | Buy |
16,250
+1,250
| +8% | +$11.6K | 0.01% | 229 |
|
|
2023
Q3 | $98.3K | Hold |
15,000
| – | – | 0.01% | 223 |
|
|
2023
Q2 | $122K | Hold |
15,000
| – | – | 0.01% | 223 |
|
|
2023
Q1 | $129K | Hold |
15,000
| – | – | 0.01% | 223 |
|
|
2022
Q4 | $139K | Hold |
15,000
| – | – | 0.02% | 204 |
|
|
2022
Q3 | $155K | Hold |
15,000
| – | – | 0.02% | 197 |
|
|
2022
Q2 | $150K | Hold |
15,000
| – | – | 0.02% | 204 |
|
|
2022
Q1 | $185K | Hold |
15,000
| – | – | 0.02% | 212 |
|
|
2021
Q4 | $260K | Hold |
15,000
| – | – | 0.02% | 198 |
|
|
2021
Q3 | $269K | Hold |
15,000
| – | – | 0.03% | 185 |
|
|
2021
Q2 | $343K | Buy |
+15,000
| New | +$343K | 0.04% | 171 |
|
|
2021
Q1 | – | Sell |
-10,000
| Closed | -$54K | – | 185 |
|
|
2020
Q4 | $54K | Hold |
10,000
| – | – | 0.01% | 200 |
|
|
2020
Q3 | $46K | Hold |
10,000
| – | – | 0.01% | 189 |
|
|
2020
Q2 | $49K | Buy |
+10,000
| New | +$49K | 0.01% | 191 |
|